These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30442225)

  • 41. Perioperative statin use is associated with decreased incidence of primary graft dysfunction after lung transplantation.
    Raphael J; Collins SR; Wang XQ; Scalzo DC; Singla P; Lau CL; Kozower BD; Durieux ME; Blank RS
    J Heart Lung Transplant; 2017 Sep; 36(9):948-956. PubMed ID: 28552627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term effects of primary graft dysfunction after heart transplantation.
    Settepani F; Pedrazzini GL; Olivieri GM; Merlanti B; Cannata A; Lanfranconi M; Frigerio M; Russo CF
    J Card Surg; 2022 May; 37(5):1290-1298. PubMed ID: 35229361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early postoperative hemodynamic instability after heart transplantation - incidence and metabolic indicators.
    Kędziora A; Piątek J; Hymczak H; Wasilewski G; Guzik B; Drwiła R; Kapelak B; Sobczyk D; Konstanty-Kalandyk J; Wierzbicki K
    BMC Anesthesiol; 2021 Oct; 21(1):236. PubMed ID: 34600476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe and Moderate Primary Graft Dysfunction in Adult Heart Recipients.
    Stefen SP; Tenório DF; Cirillo GCG; Gaspar SF; Oliveira KAS; Gaiotto FA; Jatene FB
    Braz J Cardiovasc Surg; 2023 Apr; 38(2):214-218. PubMed ID: 36592073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of right ventricular function on the development of primary graft dysfunction after lung transplantation.
    Pérez-Terán P; Roca O; Rodríguez-Palomares J; Sacanell J; Leal S; Solé J; Rochera MI; Román A; Ruiz-Rodríguez JC; Gea J; Evangelista A; Masclans JR
    J Heart Lung Transplant; 2015 Nov; 34(11):1423-9. PubMed ID: 26169669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation.
    Geube MA; Perez-Protto SE; McGrath TL; Yang D; Sessler DI; Budev MM; Kurz A; McCurry KR; Duncan AE
    Anesth Analg; 2016 Apr; 122(4):1081-8. PubMed ID: 26991618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moderate-severe primary graft dysfunction after pediatric heart transplantation.
    Mowers KL; Simpson KE; Gazit AZ; Eghtesady P; Canter CE; Castleberry CD
    Pediatr Transplant; 2019 Mar; 23(2):e13340. PubMed ID: 30609166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.
    Buchan TA; Moayedi Y; Truby LK; Guyatt G; Posada JD; Ross HJ; Khush KK; Alba AC; Foroutan F
    J Heart Lung Transplant; 2021 Jul; 40(7):642-651. PubMed ID: 33947602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary Graft Dysfunction After Isolated Heart Transplantation　- Incidence, Risk Factors, and Clinical Implications Based on a Single-Center Experience.
    Rhee Y; Kim HJ; Kim JJ; Kim MS; Lee SE; Yun TJ; Lee JW; Jung SH
    Circ J; 2021 Aug; 85(9):1451-1459. PubMed ID: 33867405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.
    Prekker ME; Nath DS; Walker AR; Johnson AC; Hertz MI; Herrington CS; Radosevich DM; Dahlberg PS
    J Heart Lung Transplant; 2006 Apr; 25(4):371-8. PubMed ID: 16563963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation.
    Truby LK; Kwee LC; Agarwal R; Grass E; DeVore AD; Patel CB; Chen D; Schroder JN; Bowles D; Milano CA; Shah SH; Holley CL
    J Heart Lung Transplant; 2021 Dec; 40(12):1589-1598. PubMed ID: 34511330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.
    Samano MN; Fernandes LM; Baranauskas JC; Correia AT; Afonso JE; Teixeira RH; Caramori ML; Pêgo-Fernandes PM; Jatene FB
    Transplant Proc; 2012 Oct; 44(8):2462-8. PubMed ID: 23026621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk assessment and outcomes of vasoplegia after cardiac surgery.
    Tsiouris A; Wilson L; Haddadin AS; Yun JJ; Mangi AA
    Gen Thorac Cardiovasc Surg; 2017 Oct; 65(10):557-565. PubMed ID: 28612323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Right Heart Failure While on Left Ventricular Assist Device Support Is Associated with Primary Graft Dysfunction.
    King PM; Raymer DS; Shuster J; Crain M; Bhatia A; Hartupee J; Schilling JD
    ASAIO J; 2020; 66(10):1137-1141. PubMed ID: 33136601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relation of Left Ventricular Assist Device Infections With Cardiac Transplant Outcomes.
    Parikh A; Halista M; Raymond S; Feinman J; Mancini D; Mitter S; Barghash M; Trivieri M; Contreras J; Taimur S; Roldan J; Murphy J; Pawale A; Anyanwu A; Moss N; Lala A; Pinney S
    Am J Cardiol; 2021 Dec; 160():67-74. PubMed ID: 34615608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung Transplant.
    Porteous MK; Ky B; Kirkpatrick JN; Shinohara R; Diamond JM; Shah RJ; Lee JC; Christie JD; Kawut SM
    Am J Respir Crit Care Med; 2016 Jun; 193(12):1392-400. PubMed ID: 26745666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
    Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
    Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long-term survival.
    Bermudez CA; Adusumilli PS; McCurry KR; Zaldonis D; Crespo MM; Pilewski JM; Toyoda Y
    Ann Thorac Surg; 2009 Mar; 87(3):854-60. PubMed ID: 19231405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.
    Lee JC; Christie JD; Keshavjee S
    Semin Respir Crit Care Med; 2010 Apr; 31(2):161-71. PubMed ID: 20354929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Donor predicted heart mass as predictor of primary graft dysfunction.
    Gong TA; Joseph SM; Lima B; Gonzalez-Stawinski GV; Jamil AK; Felius J; Qin H; Saracino G; Rafael AE; Kale P; Hall SA
    J Heart Lung Transplant; 2018 Jul; 37(7):826-835. PubMed ID: 29699850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.